LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (6)
2024
-
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
Neuron, Vol. 112, Núm. 17, pp. 2886-2909.e16
2023
-
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350
2018
-
Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy
Journal of Neuroimmunology, Vol. 319, pp. 68-70
2017
2014
-
Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats
Neuropharmacology, Vol. 79, pp. 726-737
2005
-
A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease
Neurology, Vol. 64, Núm. 9, pp. 1578-1585